ICD-10 category · Morphology of neoplasms · M856-M858
M858 Thymic epithelial neoplasms
26 codes under M858 in the South African Master Industry Table 2021, 26 valid for clinical use.
| Code | Description | Use | Benefits |
|---|---|---|---|
| M8580/0 | Thymoma, benign (D15.0) | Valid · not as primary | — |
| M8580/1 | Thymoma, NOS, uncertain whether benign or malignant | Valid · not as primary | — |
| M8580/3 | Thymoma, malignant, NOS, malignant, primary site (C37.9) | Valid · not as primary | — |
| M8580/6 | Thymoma, malignant, NOS, malignant, metastatic site | Valid · not as primary | — |
| M8581/1 | Thymoma, type A, NOS, uncertain whether benign or malignant | Valid · not as primary | — |
| M8581/3 | Thymoma, type A, malignant, primary site (C37.9) | Valid · not as primary | — |
| M8581/6 | Thymoma, type A, malignant, metastatic site | Valid · not as primary | — |
| M8582/1 | Thymoma, type AB, NOS, uncertain whether benign or malignant | Valid · not as primary | — |
| M8582/3 | Thymoma, type AB, malignant, primary site (C37.9) | Valid · not as primary | — |
| M8582/6 | Thymoma, type AB, malignant, metastatic site | Valid · not as primary | — |
| M8583/1 | Thymoma, type B1, NOS, uncertain whether benign or malignant | Valid · not as primary | — |
| M8583/3 | Thymoma, type B1, malignant, primary site (C37.9) | Valid · not as primary | — |
| M8583/6 | Thymoma, type B1, malignant, metastatic site | Valid · not as primary | — |
| M8584/1 | Thymoma, type B2, NOS, uncertain whether benign or malignant | Valid · not as primary | — |
| M8584/3 | Thymoma, type B2, malignant, primary site (C37.9) | Valid · not as primary | — |
| M8584/6 | Thymoma, type B2, malignant, metastatic site | Valid · not as primary | — |
| M8585/1 | Thymoma, type B3, NOS, uncertain whether benign or malignant | Valid · not as primary | — |
| M8585/3 | Thymoma, type B3, malignant, primary site (C37.9) | Valid · not as primary | — |
| M8585/6 | Thymoma, type B3, malignant, metastatic site | Valid · not as primary | — |
| M8586/3 | Thymic carcinoma, NOS, malignant, primary site (C37.9) | Valid · not as primary | — |
| M8586/6 | Thymic carcinoma, NOS, malignant, metastatic site | Valid · not as primary | — |
| M8587/0 | Ectopic hamartomatous thymoma, benign | Valid · not as primary | — |
| M8588/3 | Spindle epithelial tumour with thymus-like element, malignant, primary site | Valid · not as primary | — |
| M8588/6 | Spindle epithelial tumour with thymus-like element, malignant, metastatic site | Valid · not as primary | — |
| M8589/3 | Carcinoma showing thymus-like element, malignant, primary site | Valid · not as primary | — |
| M8589/6 | Carcinoma showing thymus-like element, malignant, metastatic site | Valid · not as primary | — |
Source and terms
Reproduced from the national table, unaltered.
The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page
Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.
ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.
Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.
Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.
In GreenNotes
Code the consultation once. The invoice and the claim pick it up.
GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.